NDC 62856-212 – Leqembi
Lecanemab 100 mg/mL · Injection, Solution · Intravenous
Product NDC62856-212
Product details
- Brand name
- Leqembi
- Generic name
- Lecanemab
- Labeler
- Eisai Inc.
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- BLA · BLA761269
- Marketed since
- January 6, 2023
- Listing expires
- December 31, 2027
- Pharmacologic class
- Amyloid Beta-directed Antibody
Active ingredients
- Lecanemab 100 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 62856-212-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (62856-212-01) / 2 mL in 1 VIAL, SINGLE-DOSE | Jan 6, 2023 |
Other Leqembi products
- 62856-215 Lecanemab 100 mg/mL · Injection, Solution · Eisai Inc.